RENO, Nev. – “The New Rules of Biotech: A Founder’s Guide to Building Great Companies,” by biotechnology founder and industry operator David Craig, is now available in hardcover ($29.99) and as an audiobook on Google Play. The new formats join the previously released paperback ($21.99) and Kindle ($11.99) editions on Amazon, giving founders, investors, board members, and operators flexibility in how they consume the material.
The book argues that the biotech playbook from 2021 is obsolete. Capital is more expensive, the Food and Drug Administration (FDA) bar has shifted, and the Inflation Reduction Act has altered the economics of drug development before approval. Investors now demand capital efficiency and a clear path to value, rather than funding ideas based on slides. “The New Rules of Biotech” aims to serve as an operating manual for building companies under these conditions.
Drawing on his experience founding and running a preclinical biotech firm, Craig covers topics such as choosing between platforms and assets, selecting affordable modalities, raising seed rounds against milestones rather than hope, and using non-dilutive capital strategically. The book walks readers through Investigational New Drug (IND)-enabling work, Chemistry, Manufacturing, and Controls (CMC), clinical decisions, term sheets, boards, business development, and exits like acquisitions and initial public offerings (IPOs).
Each chapter includes takeaways for operators and separate insights for investors and advisors, catering to both sides of the negotiation table. The audiobook version makes the content accessible to listeners on the go.
Craig founded his company partly due to a family connection to RYR-1 related congenital muscular dystrophy, a rare genetic muscle disease. That personal link underscores the book’s argument that biotech company building carries responsibilities beyond financial returns.
“Founders and operators take in ideas in different ways,” Craig said. “The hardcover is there for the people who want a durable copy on the desk, the paperback and Kindle for everyone else, and the audiobook on Google Play for those who prefer to listen on the move. The message is the same across all of them: build for the market that exists now, not the one that existed in 2021.”
The book is published by D. Craig Consulting LLC and is available at the following links:
Hardcover: https://www.amazon.com/dp/B0H5KN1BLW
Paperback: https://www.amazon.com/dp/B0H4WZV6CW
Kindle: https://www.amazon.com/dp/B0GX38YLJ7
Audiobook (Google Play): https://play.google.com/store/audiobooks/details?id=AQAAAEB6fmE-CM
The release of these formats broadens access to a guide that addresses the real-world challenges facing biotech entrepreneurs today, making it a timely resource for an industry navigating a changed landscape.
